David Cole, PhD

Oxford, United Kingdom
ave is a recognised expert in immune-oncology with over 15 years’ experience, including research leading to the discovery and validation of novel drug candidates plus development of collaborations with academia and industry. In his academic career Dave has published over 100 articles, and worked as a principal investigator and Wellcome Trust Fellow at Cardiff University, where he also carried out postdoctoral work after he received his D.Phil in Molecular Immunology from the University of Oxford.
Speaking In
4:45 PM - 5:00 PM
Wednesday, June 7
Accession Therapeutics is developing a new generation of immunotherapies for solid tumors. …
Session Room 104B